Contract HT942523C0078

Hexamer Therapeutics Inc. · Department Of Defense · September 25, 2023

Firm Fixed PriceFull & Open CompetitionNAICS 541714

Hexamer Therapeutics Inc. was awarded a federal contract by Department Of Defense (Defense Health Agency) on September 25, 2023 for $3.93 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Pullman, WA. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on November 25, 2025.

Obligated to date
$3.93M
$3,928,061
Current value
$3.93M
Modifications
3
Latest November 25, 2025

Contract details

PIID
HT942523C0078
Award type
Definitive Contract
Pricing
Firm Fixed Price
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
Product / service
Health R&D Services; Health Care Services; Basic Research
Place of performance
Pullman, WA
First action
September 25, 2023
Latest action
November 25, 2025

Description

SELF-ASSEMBLING, MOLECULAR CARRIER VACCINE PLATFORM FOR DEPLOYMENT DURING AN INFECTIOUS DISEASE PANDEMIC. HIGHLY MODULAR IN THAT DIFFERENT TARGETS CAN RAPIDLY BE COUPLED TO THE SCAFFOLD TO MODIFY A CU

Modification timeline

  • November 25, 2025
    Mod P00003
    SELF-ASSEMBLING, MOLECULAR CARRIER VACCINE PLATFORM FOR DEPLOYMENT DURING AN INFECTIOUS DISEASE PANDEMIC. HIGHLY MODULAR IN THAT DIFFERENT TARGETS CAN RAPIDLY B
    $0
  • March 27, 2025
    Mod P00002
    PEPTIDE BASED, SELF-ASSEMBLING, MOLECULAR CARRIER (SCAFFOLD) VACCINE PLATFORM IDEAL FOR DEPLOYMENT DURING AN INFECTIOUS DISEASE PANDEMIC BY OFFERING MANY ADVANT
    $0
  • November 27, 2023
    Mod P00001
    RESEARCH AND DEVELOPMENT SERVICES BA230121 TITLED SELF ASSEMBLING VACCINE PLATFORM
    $-0
  • September 25, 2023
    Base award
    RESEARCH AND DEVELOPMENT SERVICES BA230121 TITLED SELF ASSEMBLING VACCINE PLATFORM
    $3.93M

Similar contracts

RecipientAgencyDateObligated
Avian, LlcDepartment Of DefenseDecember 31, 2025$54.05M
Rtx Bbn Technologies, Inc.Department Of DefenseDecember 29, 2025$4.36M
Council On Strategic Risks (The)Department Of DefenseDecember 23, 2025$356.6K
Eagle Integrated Services, LlcDepartment Of DefenseDecember 23, 2025$1.93M
Ssi-Venesco Jv LlcDepartment Of DefenseDecember 23, 2025$144.5K
Techwerks LlcDepartment Of DefenseDecember 23, 2025$2.21M

Top contractors in NAICS 541714

Lifetime obligated dollars across all federal contracts in this NAICS code.

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract HT942523C0078?

Contract HT942523C0078 is a federal contract awarded to Hexamer Therapeutics Inc. by Department Of Defense on September 25, 2023 for $3.93 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 3 times since the base award.

Who won contract HT942523C0078?

Hexamer Therapeutics Inc. won contract HT942523C0078 from Department Of Defense.

How much is contract HT942523C0078 worth?

Contract HT942523C0078 has obligated $3.93 million to date.